Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.65 USD | -6.77% | -3.30% | -32.15% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.15% | 5.29B | |
-1.62% | 89.22B | |
+2.24% | 40.49B | |
-15.31% | 32.79B | |
+63.43% | 26.23B | |
-22.08% | 14.52B | |
-7.84% | 13.09B | |
-42.60% | 11.6B | |
-12.64% | 11.5B | |
+5.09% | 8.82B |
- Stock Market
- Equities
- APLS Stock
- News Apellis Pharmaceuticals, Inc.
- Apellis Pharmaceuticals : Wedbush Adjusts Price Target on Apellis Pharmaceuticals to $42 From $40, Maintains Neutral Rating